drugset / Trial / NCT04671563
Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate
Phase 4
Completed
28 enrolled
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate pharmacokinetic profiles of Viproof Film Coated Tablets 300 mg manufactured by Yung Shin Parm. Ind. Co., Ltd., Taiwan and Viread Tablets manufactured by Patheon, Inc. in terms of plasma concentrations of tenofovir after a single oral dose of 300 mg tenofovir disoproxil fumarate in healthy subjects under fasting conditions.
Timeline
- Start
- 2019-04-22
- Primary completion
- 2020-05-09
- Completion
- 2020-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |
Indications
No indication recorded.